April 25, 2018 | St. Joseph’s Regional Medical Center, Auditorium #2
May 2, 2018 | Palisades Medical Center
May 9, 2018 | Hackensack UMC at Pascack Valley
May 16, 2018 | Hackensack University Medical Center, Hekemian Conference Center
May 23, 2018 | St. Joseph’s Regional Medical Center, Auditorium #2
June 6, 2018 | Courtyard Jersey City Newport
June 13, 2018 | Hackensack UMC at Pascack Valley
June 20, 2018 | Hackensack University Medical Center
June 27, 2018 | St. Joseph’s Regional Medical Center
* All seminars are Wednesdays from 6:30-8:30pm
Feel full for longer periods of time with vBloc Therapy. Find out if you are a candidate for this safe and effective weight-loss solution.
vBLOC Therapy | Neurometabolic Therapy
vBloc Neurometabolic therapy allows patients to lose weight by reducing their food intake, helping them feel less hungry and more “full” for longer periods of time. Unlike other weight-loss treatments that alter your stomach and are designed to prevent your body from absorbing nutrients, vBloc weight loss therapy targets the source of your hunger – leaving your body intact. vBloc is FDA approved for patients whose BMI is between 35 and 45.
Our board-certified New Jersey physicians are here to provide you with individualized care and are committed to guide you on your journey to long-term success.
- Reduces the feeling of hunger between meals and hastens feeling full during meals
- Successful long-term weight loss with compliance to exercise and a healthy diet choice
- Reduces appetite
- Lowers digestive enzyme secretion
- Allows you to enjoy a normal diet and way of life
- Lower complication rate than traditional weight-loss device procedures
- On average, qualified participants lost 28% of their excess weight in one year
- Does not require you to change what you eat or adopt a low-calorie diet
The Science Behind Vbloc
The vagus nerve is a two-way communication between the brain and digestive system. vBloc therapy surgically blocks impulses that alert you when you are hungry from reaching your digestive system.
vBloc therapy targets vagal function by blocking the signals carried along this nerve, which in turn reduces appetite and leads to weight loss by limiting stomach expansion and reducing the frequency and intensity of stomach contractions. vBloc therapy may also reduce the absorption of calories by decreasing the secretion of digestive enzymes. Intermittent therapy allows the vagus nerve to return to normal function between active therapy sessions to limit the body’s natural tendency to circumvent the therapy.
For additional information, all prospective patients are invited to attend a free educational seminar.
Seminars are a great source of information about the procedure you are considering, and they allow you to meet the surgeons as well as ask any questions you may have. You may also have the opportunity to meet some post-operative patients.